Assessment of myocardial perfusion with Tc-99m: Image is everything

Journal of Nuclear Cardiology

Volumn 16, Issue 4, 2009, Pages 493-496

  Dahlberg, Seth T ^a  

^a UMASS MEMORIAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOMETHOXYISOPROPYL ISOCYANIDE TECHNETIUM TC 99M; DIMETHOXYPHOSPHINOETHANE; DIMETHYLPHOSPHINOETHANE; DIPYRIDAMOLE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; TEBOROXIME; TECHNETIUM 99M; TERT BUTYL ISOCYANIDE TECHNETIUM TC 99M; TETROFOSMIN TC 99M; THALLIUM 201; TRIMETHYLPHOSPHITE; UNCLASSIFIED DRUG;

ANGIOCARDIOGRAPHY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG SYNTHESIS; DRUG UPTAKE; EDITORIAL; FEASIBILITY STUDY; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HUMAN; HYPEREMIA; ISOLATED HEART; ISOTOPE LABELING; LIVER CLEARANCE; NON INVASIVE PROCEDURE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANIMALS; CARDIOLOGY; CORONARY ARTERY DISEASE; HUMANS; KINETICS; MYOCARDIAL PERFUSION IMAGING; MYOCARDIUM; ORGANOTECHNETIUM COMPOUNDS; PERFUSION; PROGNOSIS; RADIOPHARMACEUTICALS; TECHNETIUM; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 70249096634     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12350-009-9082-0     Document Type: Editorial

References (41)

1. Zaret BL, Strauss HW, Martin ND, Wells HP Jr, Flamm MD Jr. Noninvasive regional myocardial perfusion with radioactive potassium: Study of patients at rest, with exercise and during angina pectoris. N Engl J Med 1973;288:809-12.
2. Lebowitz E, Greene MV, Fairchild R, Bradley-Moore PR, Atkins HL, Ansari AN, et al. Thallium-201 for medical use. I. J Nucl Med 1975;16:151-5.
3. Nielsen AP, Morris KG, Murdock R, Bruno FP, Cobb FR. Linear relationship between the distribution of thallium-201 and blood flow in ischemic and nonischemic myocardium during exercise. Circulation 1980;61:797-801.
4. Grunwald AM, Watson DD, Holzgrefe HH Jr, Irving JF, Beller GA. Myocardial thallium-201 kinetics in normal and ischemic myocardium. Circulation 1981;64:610-8.
5. Leppo JA, MacNeil PB, Moring AF, Apstein CS. Separate effects of ischemia, hypoxia, and contractility on thallium-201 kinetics in rabbit myocardium. J Nucl Med 1986;27:66-74.
6. Pohost GM, Zir LM, Moore RH, McKusick KA, Guiney TE, Beller GA. Differentiation of transiently ischemic from infarcted myocardium by serial imaging after a single dose of thallium-201. Circulation 1977;55:294-302.
7. Deutsch E, Bushong W, Glavan KA, Elder RD, Sodd VJ, Scholz KL, et al. Heart imaging with cationic complexes of technetium. Science 1981;214:85-6.
8. Kampf G, Muenze R, Knop G, Seifert S. Evaluation of potential heart affine compounds by use of the isolated perfused rat heart. Eur J Nucl Med 1987;13:410-5.
9. Okada RD, Williams SJ, Glover DK, Dragatokis D. Cardiac imaging and myocardial kinetics of technetium-tertiary butyl-isonitrile during dipyridamole-induced hyperemia. Am Heart J 1988;116:979-88.
10. Gerson MC, Deutsch EA, Nishiyama H, Libson KF, Adolph RJ, Grossman LW, et al. Myocardial perfusion imaging with 99 m Tc-DMPE in man. Eur J Nucl Med 1983;8:371-4.
11. Gerson MC, Deutsch EA, Libson KF, Adolph RJ, Ketring AR, Vanderheyden J-L, et al. Myocardial scintigraphy with 99 m Tc-tris-DMPE in man. Eur J Nucl Med 1984;9:403-7.
12. Sia IB, Holman BL, McKusick K, Rigo P, Gillis F, Sporn V, et al. The utilization of Tc-99m-TBI as a myocardial perfusion agent in exercise studies: Comparison with Tl-201 thallous chloride and examination of its biodistribution in humans. Eur J Nucl Med 1986;12:333-6.
13. Gerundini P, Savi A, Gilardi MC, Margonato A, Vicedomini G, Zecca L, et al. Evaluation in dogs and humans of three potential technetium-99m myocardial perfusion agents. J Nucl Med 1986;27:409-16.
14. Deutsch E, Ketring AR, Libson K, Vanderheyden J-L, Hirth WW. The Noah's ark experiment: Species dependent biodistributions of cationic 99 m Tc complexes. Nucl Med Biol 1989;16:191-232.
15. Maublant JC, Moins N, Gachon P. Uptake and release of two new Tc-99m labeled myocardial blood flow imaging agents in cultured cardiac cells. Eur J Nucl Med 1989;15:180-2.
16. Maublant JC, Moins N, Gachon P, Renoux M, Zhang Z, Veyre A. Uptake of technetium-99m-teboroxime in cultured myocardial cells: Comparison with thallium-201 and technetium-99m-sestamibi. J Nucl Med 1993;34:255-9.
17. Beanlands R, Muzik O, Nguyen N, Petry N, Schwaiger M. The relationship between myocardial retention of technetium-99m teboroxime and myocardial blood flow. J Am Coll Cardiol 1992;20:712-9.
18. Stewart RE, Schwaiger M, Hutchins GD, Chiao P, Gallagher KP, Nguyen N, et al. Myocardial clearance kinetics of technetium-99m-SQ30217: A marker of regional myocardial blood flow. J Nucl Med 1990;31:1183-90.
19. Rumsey WL, Rosenspire KC, Nunn AD. Myocardial extraction of teboroxime: Effects of teboroxime interaction with blood. J Nucl Med 1992;33:94-101.
20. Dahlberg ST, Gilmore MP, Leppo JA. Interaction of technetium 99m-labeled teboroxime with red blood cells reduces the compound's extraction and increases apparent cardiac washout. J Nucl Cardiol 1994;1:270-9.
21. Seldin DW, Johnson LL, Blood DK, Muschel MJ, Smith KF, Wall RM, et al. Myocardial perfusion imaging with technetium-99m SQ30217: Comparison with thallium-201 and coronary anatomy. J Nucl Med 1989;30:312-9.
22. Carvalho PA, Chiu ML, Kronauge JF, Kawamure M, Jones AG, Holman BL, et al. Subcellular distribution and analysis of technetium-99m-MIBI in isolated perfused rat hearts. J Nucl Med 1992;33:1516-21.
23. Leppo JA, Meerdink DJ. Comparison of the myocardial uptake of a technetium-labeled isonitrile analogue and thallium. Circ Res 1989;65:632-9.
24. Glover DK, Ruiz M, Edwards NC, Cunningham M, Simanis JP, Smith WH, et al. Comparison between 201Tl and 99mTc sestamibi uptake during adenosine-induced vasodilation as a function of coronary stenosis severity. Circulation 1995;91:813-20.
25. Miller DD, Donohue TJ, Younis LT, Bach RG, Aguirre FV, Wittry MD, et al. Correlation of pharmacological 99mTc-sestamibi myocardial perfusion imaging with poststenotic coronary flow reserve in patients with angiographically intermediate coronary artery stenoses. Circulation 1994;89:2150-60.
26. Hendel RC, McSherry B, Karimeddini M, Leppo JA. Diagnostic value of a new myocardial perfusion agent, teboroxime (SQ30217), utilizing a rapid planar imaging protocol: Preliminary results. J Am Coll Cardiol 1990;16:855-61.
27. Smith AM, Gullberg GT, Christian PE, Datz FL. Kinetic modeling of teboroxime using dynamic SPECT imaging of a canine model. J Nucl Med 1994;35:484-95.
28. Chua T, Kiat H, Germano G, Takemoto K, Fernandez G, Biasio Y, et al. Rapid back to back adenosine stress/rest technetium-99m teboroxime myocardial perfusion SPECT using a triple-detector camera. J Nucl Med 1993;34:1485-93.
29. Vanzetto G, Fagret D, Ghezzi C. Tc-99m N-NOET: Chronicle of a unique perfusion imaging agent and a missed opportunity? J Nucl Cardiol 2004;11:647-50.
30. Vanzetto G, Calnon DA, Ruiz M, Watson DD, Pasqualini R, Beller GA, et al. Myocardial uptake and redistribution of 99mTc-N-NOET in dogs with either sustained coronary low flow or transient coronary occlusion: comparison with 201Tl and myocardial blood flow. Circulation 1997;96:2325-31.
31. Sinusas AJ, Shi Q-X, Saltzberg MT, Vitols P, Jain D, Wackers FJTh, et al. Technetium-99m-tetrofosmin to assess myocardial blood flow: Experimental validation in an intact canine model of ischemia. J Nucl Med 1994;35:664-71.
32. Glover DK, Ruiz M, Yang JY, Smith WH, Watson DD, Beller GA. Myocardial 99mTc-tetrofosmin uptake during adenosine-induced vasodilatation with either a critical or mild coronary stenosis: Comparison with 201Tl and regional myocardial blood flow. Circulation 1997;96:2332-8.
33. Zaret BL, Rigo P, Wackers FJ, Hendel RC, Braat SH, Iskandrian AS, et al. Myocardial perfusion imaging with 99mTc tetrofosmin. Comparison to 201Tl imaging and coronary angiography in a phase III multicenter trial. Tetrofosmin International Trial Study Group. Circulation 1995;91:313-9.
34. He Z, Hsieh WY, Kim YS, Liu S. Evaluation of novel cationic 99mTc(I)-tricarbonyl complexes as potential radiotracers for myocardial perfusion imaging. Nucl Med Biol 2006;33:1045-53.
35. Kim YS, Wang J, Broisat A, Glover DK, Liu S. Tc-99m-N-MPO: Novel cationic Tc-99m radiotracer for myocardial perfusion imaging. J Nucl Cardiol 2008;15:535-46.
36. Kim YS, He Z, Hsieh WY, Liu S. Impact of bidentate chelators on lipophilicity, stability, and biodistribution characteristics of cationic 99mTc-nitrido complexes. Bioconjug Chem 2007;18:929-36.
37. Liu S, He Z, Hsieh WY, Kim YS. Evaluation of novel cationic (99m)Tc-nitrido complexes as radiopharmaceuticals for heart imaging: Improving liver clearance with crown ether groups. Nucl Med Biol 2006;33:419-32.
38. Bolzati C, Cavazza-Ceccato M, Agostini S, Tokunaga S, Casara D, Bandoli G. Subcellular distribution and metabolism studies of the potential myocardial imaging agent [99mTc(N)(DBODC)(PNP5)]+. J Nucl Med 2008;49:1336-44.
39. Cittanti C, Uccelli L, Pasquali M, Boschi A, Flammia C, Bagatin E, et al. Whole-body biodistribution and radiation dosimetry of the new cardiac tracer 99mTc-N-DBODC. J Nucl Med 2008;49:1299-304.
40. Hatada K, Ruiz M, Riou LM, Lima RL, Goode AR, Watson DD, et al. Organ biodistribution and myocardial uptake, washout, and redistribution kinetics of Tc-99m N-DBODC5 when injected during vasodilator stress in canine models of coronary stenoses. J Nucl Cardiol 2006;13:779-90.
41. Hatada K, Riou LM, Ruiz M, Yamamichi Y, Duatti A, Lima RL, et al. 99mTc-N-DBODC5, a new myocardial perfusion imaging agent with rapid liver clearance: Comparison with 99mTc-sestamibi and 99mTc-tetrofosmin in rats. J Nucl Med 2004;45:2095-101.